The world’s first phase III trials of an inactivated COVID-19 vaccine in the United Arab Emirates reached the target of 15,000 volunteers in less than a month, with Americans of 107 nationalities in the program.
Managed through G42 Healthcare in partnership with the Ministry of Health and Prevention of the United Arab Emirates (MOHAP), the Ministry of Health of Abu Dhabi and the Abu Dhabi Health Services Society (SEHA), the trials effectively decided and vaccinated 15,000 volunteers with the first of two vaccines. they get the process. The inactivated vaccine was developed through Sinopharm CNBG, one of the leading vaccine manufacturers.
Volunteers can still register on the www.4humanity.ae portal.
In the future, volunteers enter the next phase, get their injection at the moment and continue with normal monitoring and fitness checks, with continuous and comprehensive fitness facilities to ensure their well-being.
Volunteers make up 107 nationalities and diverse demographic groups, adding more than 4,500 Emirati. More than 140 doctors, 300 nurses and much more administrative and technical staff are helping to facilitate the testing of the vaccine.
Volunteers received fast and undeniable protocols, allowing them to go to DNAEC’s unansed care centres in Abu Dhabi and the Al Qarain Health Center in Sharjah to be registered, screened and given their first vaccination on a singles visit.
The Ministry of Health and Prevention of the United Arab Emirates (MOHAP), the Ministry of Health of Abu Dhabi, the Abu Dhabi Health Services Company, Sinopharm and G42 Healthcare expressed their gratitude to all volunteers for their service to humanity. Through its participation in these historical trials, the world has taken a fundamental step towards the progression of the first tested and safe vaccine.
Commenting on the achievement of this milestone, Abdul Rahman bin Mohammed Al Owais, Minister of Health and Prevention, said: “This is a very proud day for all those related to these essays and we look forward to proceed to proceed to the paintings that will come in the coming months.”
Taking this step is a testament to the commitment and association of the competent government that is combined to conduct as many medical tests as possible and provide mandatory care to the infected, while strengthening the cooperation of the United Arab Emirates with foreign partners. to expand a safe vaccine. contrary to the disease. “
Sheikh Abdullah bin Mohammed Al Hamed, president of Abu Dhabi’s Ministry of Health, the first individual in the world to start testing the phase III inactivated vaccine opposed to COVID-19 and has already won the first and last vaccine.
He added: “I was incredibly proud to have been the first volunteer and since then it has been comforting to see how the country has become a combined country, helping us achieve our player goal in just 4 weeks since the trials began. people, whom Americans around the world call home, and in combicountry we are committed to finding a global solution for COVID-19.”
United Arab Emirates lead researcher Sheikh Khalifa Medical City CMO and chairman of COVID-19’s National Committee for Clinical Management, Dr. Nawal Ahmed Alkaabi, said: “This is a glorious achievement and the importance of caring in these clinical trials has captured the country’s care and the 15,000 volunteers who have mobilized to participate. Once again, it shows the love and commitment of all who live and paint here in the United Arab Emirates to play its component for the intelligence of humanity.
“I would like to express my gratitude to the leaders of the United Arab Emirates for allowing these pioneering trials to take a stand and, of course, to our volunteers and to clinical and administrative staff who are incredibly committed to their professionalism in treating our volunteers so temporally and efficiently.
G42 Healthcare CEO Ashish Koshy said: “The 107 nationalities that have volunteered are a stark justification for our resolve to inspire Sinopharm CNBG to marry us in the United Arab Emirates because of the country’s incredible ethnic diversity and demographics. Population.
“But this milestone only marks the final touch of the first phase of volunteer vaccination. The combined clinical and clinical groups will now ensure proper control of our 15,000 volunteers at the level of their 42-day trip, which includes normal and of course returns for a moment the injection of the inactivated vaccine.”
Jingjin Zhu, president of Sinopharm Group Biological Products, said: “The speed of these trials to date and the diversity of volunteers who have been vaccinated have completely reinforced our resolve that the United Arab Emirates was an ideal position to verify our inactivated vaccine and succeed in the widest diversity of demographic and ethnic volunteers.
“We would like to thank our partners G42 Healthcare and the UAE fitness government for their hard work and professionalism, and look forward to continuing good fortune as the tests spread in the weeks and months to come.
Meanwhile, in the first extension of the outdoor program in the United Arab Emirates, many others now volunteer for Phase III trials in Bahrain, which are controlled through G42 Healthcare with bahrain’s Ministry of Health. These effects will be part of the global trials that began in the UAE and will use the same Sinopharm CNBG inactivated vaccine and the same clinical protocols.
Plans are at a complex level to open more centers elsewhere to ensure that the broader ones have an effect and an opportunity for Americans to participate and enroll in the 4Humanity campaign.
The trial is part of a series of national projects aimed at selling population fitness and strengthening UAE medical and progression capacity, adding local capacity to manufacture the vaccine.